Overview

Comprehensive Acupuncture for Depressive Disorder With Comorbid Psychogenic Pain

Status:
Unknown status
Trial end date:
2019-06-30
Target enrollment:
0
Participant gender:
All
Summary
Experimental and clinical studies have indicated that acupuncture has a good effect for depression and comorbid pain. The purpose of this research is to compare the effect of comprehensive electro-acupuncture therapy and western medicine citalopram for for depressive disorder with comorbid psychogenic pain. This research is a assessor blinded, randomized controlled trials. 60 patients will be randomly divided into comprehensive electro-acupuncture group and western medicine citalopram for 8 weeks treatment and the therapeutic effect is done at the end of 1,2,4,6,8 week.
Phase:
Early Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
China Academy of Chinese Medical Sciences
Treatments:
Citalopram
Dexetimide
Criteria
Inclusion Criteria:

- Conform with the diagnostic criteria of depression according to DIAGNOSTIC AND
STATISTICAL MANUAL OF MENTAL DISORDERS (DSM-5TM)

- Age from 18 to 50 year-old

- Patients with the first onset depression

- Patients with mild-to-moderate depression scored 12-30 by Montgomery scale

- Patients with one psychogenic pain at least, and the degree of VAS is 3 or more

- Volunteer participants willing to cooperate and obeying the treatment

Exclusion Criteria:

- Pregnant woman

- Patients with severe primary diseases and acute diseases of heart, brain, liver,
kidney and hematopoietic systems and infectious disease, malignant tumor

- Patients who can't stop taking drugs according to the requirement in the treatment
period

- Patients with a history of schizophrenia and other mental disorders

- Patients with cognitive impairment or personality disorders

- Patients have serious suicide idea or suicidal behavior